Bolt Biotherapeutics, Inc. Common Stock
XNAS:BOLT
4.87
$10.00 - 650.00
$4.60 - 5.00
$4.75
$5.05
$5.05
$5.08
13
4.41
15644
22226.5
1333323.64
Chart
TendieTensor AI Analysis
Company
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Fundamentals
52
-0.220000
0.303155
-3.72
100
BBG00N8MY5V9
BBG00N8MY5W8
1.92M
1.92M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own BOLT. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.